Both combinations were based on the CLivD score, hazardous alcohol use, BMI ≥35 kg/m2, 3 or more metabolic risk factors (=metabolic syndrome), and/or the AST-to-ALT ratio; further, 1 of them was additionally based on the presence of diabetes (Table 4). The gene discussed is GPT; the disease is metabolic syndrome.